0002027042-24-000002.txt : 20240807 0002027042-24-000002.hdr.sgml : 20240807 20240807133330 ACCESSION NUMBER: 0002027042-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240807 DATE AS OF CHANGE: 20240807 EFFECTIVENESS DATE: 20240807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kate Therapeutics Inc. CENTRAL INDEX KEY: 0002032702 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-520817 FILM NUMBER: 241182851 BUSINESS ADDRESS: STREET 1: 10675 SORRENTO VALLEY ROAD, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 619-614-3609 MAIL ADDRESS: STREET 1: 10675 SORRENTO VALLEY ROAD, SUITE 150 CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: Kate Therapeutics, Inc. DATE OF NAME CHANGE: 20240805 D 1 primary_doc.xml X0708 D LIVE 0002032702 Kate Therapeutics Inc. 10675 SORRENTO VALLEY ROAD, SUITE 150 SAN DIEGO CA CALIFORNIA 92121 619-614-3609 DELAWARE Kate Therapeutics, Inc. Corporation true 2020 Kevin Forrest, Ph.D. 10675 Sorrento Valley Road, Suite 150 San Diego CA CALIFORNIA 92010 Executive Officer Director Clare Ozawa, Ph.D. 10675 Sorrento Valley Road, Suite 150 San Diego CA CALIFORNIA 92010 Director Beth Seidenberg, M.D. 10675 Sorrento Valley Road, Suite 150 San Diego CA CALIFORNIA 92010 Director Biotechnology Decline to Disclose 06b false 2021-02-05 false true false 0 16000000 16000000 0 false 1 0 0 0 false Kate Therapeutics Inc. /s/ Kevin Forrest Kevin Forrest, Ph.D. Chief Executive Officer 2024-08-07